SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
1.820
+0.240 (15.19%)
Nov 13, 2026, 4:00 PM EST - Market closed
SANUWAVE Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 41.15 | 44.05 | 32.63 | 20.4 | 16.74 | 13.01 |
| 41.15 | 44.05 | 32.63 | 20.4 | 16.74 | 13.01 | |
Revenue Growth | -0.03% | 34.98% | 59.99% | 21.84% | 28.69% | 220.68% |
Cost of Revenue | 9.84 | 10.08 | 8.08 | 6.04 | 4.33 | 4.99 |
Gross Profit | 31.31 | 33.97 | 24.55 | 14.36 | 12.41 | 8.02 |
Selling, General & Admin | 27.39 | 25.22 | 17.67 | 13.57 | 20.03 | 20.28 |
Research & Development | 2.32 | 1.35 | 0.67 | 0.58 | 0.57 | 1.1 |
Operating Expenses | 30.78 | 27.46 | 19.13 | 14.9 | 21.36 | 22.17 |
Operating Income | 0.53 | 6.51 | 5.42 | -0.54 | -8.95 | -14.14 |
Interest Expense | -2.02 | -6.25 | -13.78 | -15.62 | -14.13 | -7.1 |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0 |
Other Non Operating Income (Expenses) | 6.74 | 8.87 | -31.95 | -9.64 | 16.65 | -2.62 |
EBT Excluding Unusual Items | 5.25 | 9.14 | -40.31 | -25.8 | -6.44 | -23.86 |
Gain (Loss) on Sale of Assets | -5 | - | - | - | - | - |
Asset Writedown | -0.01 | -0.2 | - | - | - | - |
Other Unusual Items | 3.43 | 2.96 | 7.26 | - | -3.85 | -3.37 |
Pretax Income | 3.67 | 11.9 | -33.06 | -25.8 | -10.29 | -27.23 |
Income Tax Expense | 0.16 | 0.09 | 0.03 | 0 | 0 | 0.03 |
Net Income | 3.52 | 11.81 | -33.08 | -25.81 | -10.29 | -27.26 |
Net Income to Common | 3.52 | 11.81 | -33.08 | -25.81 | -10.29 | -27.26 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 9 | 9 | 4 | 2 | 1 | 1 |
Shares Outstanding (Diluted) | 9 | 9 | 4 | 2 | 1 | 1 |
Shares Change | 5.22% | 103.51% | 110.82% | 44.47% | 6.00% | 37.08% |
EPS (Basic) | 0.41 | 1.38 | -7.41 | -12.19 | -7.02 | -19.72 |
EPS (Diluted) | 0.17 | 0.41 | -7.41 | -12.19 | -7.50 | -19.72 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2.6 | 1.93 | 1.97 | -4.54 | -17.17 | -6.94 |
Free Cash Flow Per Share | 0.29 | 0.21 | 0.44 | -2.14 | -11.72 | -5.02 |
Gross Margin | 76.08% | 77.11% | 75.23% | 70.41% | 74.13% | 61.68% |
Operating Margin | 1.29% | 14.78% | 16.60% | -2.65% | -53.47% | -108.70% |
Profit Margin | 8.55% | 26.82% | -101.38% | -126.52% | -61.48% | -209.52% |
Free Cash Flow Margin | 6.32% | 4.39% | 6.02% | -22.25% | -102.55% | -53.33% |
EBITDA | 1.82 | 7.49 | 6.21 | 0.49 | -8 | -12.91 |
EBITDA Margin | 4.42% | 16.99% | 19.01% | 2.39% | -47.78% | -99.20% |
D&A For EBITDA | 1.29 | 0.97 | 0.79 | 1.03 | 0.95 | 1.24 |
EBIT | 0.53 | 6.51 | 5.42 | -0.54 | -8.95 | -14.14 |
EBIT Margin | 1.29% | 14.78% | 16.60% | -2.65% | -53.47% | -108.70% |
Effective Tax Rate | 4.22% | 0.72% | - | - | - | - |